CAS Number57460-41-0
Synonyms1-Cyclohexyl-3-(4-{2-hydroxy-3-[(2-methyl-2-propanyl)amino]propoxy}phenyl)urea; 1-{4-[3-(tert-Butylamino)-2-hydroxypropoxy]phenyl}-3-cyclohexylurea; Talinolol; 1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-cyclohexylurea
Molecular FormulaC20H33N3O3
Molecular Weight363.49
Purity≥95 (HPLC)%
Density1.1±0.1 g/cm3
Boiling Point520.0±50.0 °C at 760 mmHg
Melting Point160-162ºC
Appearancepowder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 57460-41-0 |
| Catalog No. | 2A-9012567 |
| Chinese Name | 他林洛尔 |
| Synonyms | 1-Cyclohexyl-3-(4-{2-hydroxy-3-[(2-methyl-2-propanyl)amino]propoxy}phenyl)urea; 1-{4-[3-(tert-Butylamino)-2-hydroxypropoxy]phenyl}-3-cyclohexylurea; Talinolol; 1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-cyclohexylurea |
| Molecular Formula | C20H33N3O3 |
| Molecular Weight | 363.49 |
| Purity | ≥95 (HPLC) |
| Density | 1.1±0.1 g/cm3 |
| Boiling Point | 520.0±50.0 °C at 760 mmHg |
| Melting Point | 160-162ºC |
| Appearance | powder |
| Storage Condition | -20°C, sealed, dry |
| HTC | 2924299090 |
| MDL Number | MFCD00864592 |
| SMILES | N(C2CCCCC2)C(=O)Nc1ccc(cc1)OCC(O)CNC(C)(C)C |
| InChI | 1S/C20H33N3O3/c1-20(2,3)21-13-17(24)14-26-18-11-9-16(10-12-18)23-19(25)22-15-7-5-4-6-8-15/h9-12,15,17,21,24H,4-8,13-14H2,1-3H3,(H2,22,23,25) |
| InChI Key | MXFWWQICDIZSOA-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 51111800 |
| MSDS | msds/12567_1_57460_41_0.pdf |
| Use of | Talinolol is a beta(1)-adrenergic receptor antagonist and a probe drug for P-glycoprotein (P-gp) activity in humans. Properties Name rac-Talinolol Synonym More Synonyms Chemical & Physical Properties Molecular Formula C20H33N3O3 Exact Mass 363.252197 PSA 82.62000 Index of Refraction 1.552 InChIKey MXFWWQICDIZSOA-UHFFFAOYSA-N Toxicological Information CHEMICAL IDENTIFICATION RTECS NUMBER : CHEMICAL NAME : Urea, N-cyclohexyl-N'-(4-(3-((1,1-dimethylethyl)amino)-2-hy droxypropoxy)phenyl)-, (+-)- CAS REGISTRY NUMBER : 57460-41-0 LAST UPDATED : DATA ITEMS CITED : MOLECULAR FORMULA : C20-H33-N3-O3 MOLECULAR WEIGHT : HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : PHARAT Pharmazie. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, Berlin DDR-1020, Ger. Dem. Rep.) V.1- 1946- Volume(issue)/page/year: 38,409,1983 Safety Information HS Code 2924299090 Synthetic Route Total: 1 Page |p|-Aminophenol... CAS#:51-78-5 rac Talinolol CAS#:57460-41-0 Literature: Eckardt; Carstens; Fiedler Pharmazie, 1975 , vol. 30, # 10 p. 633 - 637 cyclohexylisocyanate CAS#:3173-53-3 rac Talinolol CAS#:57460-41-0 Literature: Eckardt; Carstens; Fiedler Pharmazie, 1975 , vol. 30, # 10 p. 633 - 637 2-methyl-N-(oxi... CAS#:13080-65-4 1-cyclohexyl-3-... CAS#:38652-23-2 rac Talinolol CAS#:57460-41-0 Literature: Eckardt; Carstens; Fiedler Pharmazie, 1975 , vol. 30, # 10 p. 633 - 637 Precursor & DownStream Precursor 4 CAS#:51-78-5 |p|-Aminophenol... CAS#:3173-53-3 cyclohexylisocyanate CAS#:13080-65-4 2-methyl-N-(oxi... CAS#:38652-23-2 1-cyclohexyl-3-... DownStream 0 |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 30.0% |
| Transport Info | Product name: Summary 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Tabilautide | 78088-46-7 | 2A-9012561 |
| Tacalcitol | 57333-96-7 | 2A-9012562 |
| Tadanafil | 171596-29-5 | 2A-9012564 |
| Talampicillin | 47747-56-8 | 2A-9012565 |
| Talbutal | 115-44-6 | 2A-9012566 |
| Talipexole | 101626-70-4 | 2A-9012568 |
| Talniflumate | 66898-62-2 | 2A-9012569 |
| Talsaclidine | 147025-53-4 | 2A-9012570 |
| Tamarixetin | 603-61-2 | 2A-9012571 |
| Tamibarotene | 94497-51-5 | 2A-9012572 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS